The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox.
Valeant: We'll bump Allergan offer to $200 a share
source U.S. News - News http://ift.tt/1pQ7W1D
Valeant: We'll bump Allergan offer to $200 a share
source U.S. News - News http://ift.tt/1pQ7W1D
No comments:
Post a Comment